Atea Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $416 | $0 |
Gross Profit | -104 | -104 | 208 | -104 |
EBITDA | -41,345 | -39,041 | -33,214 | -37,202 |
EBIT | -39,145 | -33,318 | -37,306 | |
Net Income | -37,161 | -34,272 | -33,543 | -31,151 |
Net Change In Cash | 0 | 0 | 416 | 0 |
Free Cash Flow | -32,870 | -30,563 | -30,397 | -23,035 |
Cash | 87,721 | 119,394 | 64,696 | 98,463 |
Basic Shares | 83,747 | 85,159 | 84,463 | 84,422 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $192,180 | $351,367 |
Gross Profit | -416 | -70,090 | -260 | 351,367 |
EBITDA | -167,044 | -119,593 | -130,390 | 138,406 |
EBIT | -167,460 | -120,009 | -130,650 | 138,377 |
Net Income | -168,385 | -135,956 | -115,909 | 121,190 |
Net Change In Cash | 0 | 0 | 192,180 | 351,367 |
Cost of Revenue | -85,544 | |||
Free Cash Flow | -135,499 | -85,395 | -122,925 | -87,009 |
Cash | 64,696 | 143,823 | 188,460 | 764,375 |
Basic Shares | 84,264 | 83,389 | 83,245 | 88,249 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.44 |
2025-03-31 | -$0.40 |
2024-12-31 | -$0.40 |
